Acadia Pharmaceuticals: Below, The Stockholders Of The Company Approved The Adoption Of The Company S 2024 Equity Incentive Plan (the Plan ) At The 2024 Annual Meeting. The Company S Board Of Directors Had Previously Approved The Plan, Subject To Stockholder Approval, Financial Statements And Exhibits
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameAcadia Pharmaceuticals Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









